Bluefin Biomedicine

Bluefin Biomedicine is a biotech company in Beverly, United States, founded in 2016. It has raised $101.0M across 2 rounds, most recently a $101.0M Series B in 2021 (est.).

First-in-class antibody medicines grounded in human biology

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$101.0M
Last Round
$101.0M Series BJan 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Bluefin Biomedicine is a privately held, clinical-stage biotechnology company advancing first-in-class antibody medicines anchored in human biology. Its integrated discovery platform combines proteomics-powered antigen identification with next-generation antibody engineering to resolve target expression within complex human tissues. This human tissue-anchored approach reveals previously inaccessible biology across immune pathways and tumor-intrinsic or tumor-associated mechanisms. Guided by these insights, Bluefin advances a focused portfolio of differentiated biologics designed to address serious inflammatory and oncologic diseases where current therapies fall short.

Summary

It lists 11–50 employees. It has raised $101.0M in total across 2 rounds, most recently a $101.0M Series B round in 2021 (est.). Investors include Deerfield Management.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries B2021 (est.)
$101.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bluefin Biomedicine on Indexed.vc
<a href="https://indexed.vc/companies/bluefin-biomedicine"><img src="https://indexed.vc/api/badge/company/bluefin-biomedicine" alt="Bluefin Biomedicine on Indexed.vc" width="260" height="76" /></a>